Avastin as effective as Eylea for treating central retinal vein occlusion

Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the treatment of central retinal vein occlusion (CRVO), according to a clinical trial. After six monthly injections, treatment with either drug improved visual acuity on average from 20/100 to 20/40.
Source: ScienceDaily Headlines - Category: Science Source Type: news